Abbott Laboratories, headquartered in Abbott Park, announced Friday that there is a test that could detect positive COVID-19 results in as little as five minutes.
The test, which can deliver negative results in 13 minutes, will run on the company’s ID NOW platform, according to a news release.
The U.S. Food and Drug Administration issued Emergency Use Authorization for the fastest available molecular point of care test for the detection of novel coronavirus.
The ID NOW platform is small, lightweight and portable, according to Abbott.
“The COVID-19 pandemic will be fought on multiple fronts, and a portable molecular test that offers results in minutes adds to the broad range of diagnostic solutions needed to combat this virus,” Robert B. Ford, president and chief operating officer of Abbott, said in a statement. “With rapid testing on ID NOW, healthcare providers can perform molecular point-of-car testing outside the traditional four walls of a hospital in outbreak hotspots.”
Abbott will make ID NOW COVID-19 tests available next week to healthcare providers in urgent care settings in the United States. According to the company, the majority of ID NOW instruments are already in use in these locations. ID NOW is the most widely available molecular point-of-care testing platform in the U.S. today, according to Abbott’s website.
The company is now working with the FDA to deploy tests to areas where they can have the greatest impact, according to their website.
Source: The Daily Chronicle